Ondek Investments
Ondek Pty Ltd is an Australian biotechnology company that specializes in developing a groundbreaking drug delivery platform called the Helicobacter pylori Platform Technology (HPPT). This innovative platform harnesses the unique characteristics of the Helicobacter pylori bacterium to deliver a wide range of therapeutics, including immune modulators, biopharmaceuticals, drugs, and vaccines.
Founded by Nobel Laureate Professor Barry Marshall, Ondek is led by a world authority and co-discoverer of the Helicobacter pylori organism, who was also a co-recipient of the 2005 Nobel Prize for Medicine and Physiology. With a focus on biological delivery systems, Ondek is at the forefront of biotechnology advancements, aiming to revolutionize drug delivery and improve patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.
